Salah Ghabri

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

Gérardo Priotto, S Kasparian, Wilfried Mutombo et al. · The Lancet · 2009 · 532 citations

Veterinary Medicine, Infectious Diseases, Pharmacology +12

Nifurtimox-Eflornithine Combination Therapy for Second-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Congo

Gérardo Priotto, Saro Kasparian, D Ngouama et al. · Clinical Infectious Diseases · 2007 · 139 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report

Olena Mandrik, Johan L. Severens, Ariel Bardach et al. · Value in Health · 2021 · 107 citations · Full text

Public Affairs, Health Systems, Pharmacoeconomics +16

Three Drug Combinations for Late-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Uganda

Gérardo Priotto, Carole Fogg, Manica Balasegaram et al. · PLoS Clinical Trials · 2006 · 104 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness

Caecilia Schmid, Andrea Kuemmerle, Johannes Blum et al. · PLoS neglected tropical diseases · 2012 · 48 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +14